327 related articles for article (PubMed ID: 30347358)
21. Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.
Andersen ME
Toxicol Lett; 1995 Sep; 79(1-3):35-44. PubMed ID: 7570672
[TBL] [Abstract][Full Text] [Related]
22. Parameters for pyrethroid insecticide QSAR and PBPK/PD models for human risk assessment.
Knaak JB; Dary CC; Zhang X; Gerlach RW; Tornero-Velez R; Chang DT; Goldsmith R; Blancato JN
Rev Environ Contam Toxicol; 2012; 219():1-114. PubMed ID: 22610175
[TBL] [Abstract][Full Text] [Related]
23. Predicting blood:air partition coefficients using basic physicochemical properties.
Buist HE; Wit-Bos Ld; Bouwman T; Vaes WH
Regul Toxicol Pharmacol; 2012 Feb; 62(1):23-8. PubMed ID: 22178169
[TBL] [Abstract][Full Text] [Related]
24. A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans.
DeJongh J; Verhaar HJ; Hermens JL
Arch Toxicol; 1997; 72(1):17-25. PubMed ID: 9458186
[TBL] [Abstract][Full Text] [Related]
25. Plasma and Hepatic Concentrations of Chemicals after Virtual Oral Administrations Extrapolated Using Rat Plasma Data and Simple Physiologically Based Pharmacokinetic Models.
Kamiya Y; Otsuka S; Miura T; Takaku H; Yamada R; Nakazato M; Nakamura H; Mizuno S; Shono F; Funatsu K; Yamazaki H
Chem Res Toxicol; 2019 Jan; 32(1):211-218. PubMed ID: 30511563
[TBL] [Abstract][Full Text] [Related]
26. Ecotoxicological QSAR modeling of organic compounds against fish: Application of fragment based descriptors in feature analysis.
Khan K; Baderna D; Cappelli C; Toma C; Lombardo A; Roy K; Benfenati E
Aquat Toxicol; 2019 Jul; 212():162-174. PubMed ID: 31128417
[TBL] [Abstract][Full Text] [Related]
27. Comparison of models for the estimation of biological partition coefficients.
Payne MP; Kenny LC
J Toxicol Environ Health A; 2002 Jul; 65(13):897-931. PubMed ID: 12133236
[TBL] [Abstract][Full Text] [Related]
28. A physiologically based toxicokinetic model for the zebrafish Danio rerio.
Péry AR; Devillers J; Brochot C; Mombelli E; Palluel O; Piccini B; Brion F; Beaudouin R
Environ Sci Technol; 2014; 48(1):781-90. PubMed ID: 24295030
[TBL] [Abstract][Full Text] [Related]
29. Magnitude and mechanistic determinants of the interspecies toxicokinetic uncertainty factor for organic chemicals.
Pelekis M; Krishnan K
Regul Toxicol Pharmacol; 2004 Dec; 40(3):264-71. PubMed ID: 15546680
[TBL] [Abstract][Full Text] [Related]
30. A distributed parameter physiologically-based pharmacokinetic model for dermal and inhalation exposure to volatile organic compounds.
Roy A; Weisel CP; Lioy PJ; Georgopoulos PG
Risk Anal; 1996 Apr; 16(2):147-60. PubMed ID: 8638037
[TBL] [Abstract][Full Text] [Related]
31. Dermal permeation data and models for the prioritization and screening-level exposure assessment of organic chemicals.
Brown TN; Armitage JM; Egeghy P; Kircanski I; Arnot JA
Environ Int; 2016 Sep; 94():424-435. PubMed ID: 27282209
[TBL] [Abstract][Full Text] [Related]
32. Development of QSARs for parameterizing Physiology Based ToxicoKinetic models.
Sarigiannis DΑ; Papadaki K; Kontoroupis P; Karakitsios SP
Food Chem Toxicol; 2017 Aug; 106(Pt A):114-124. PubMed ID: 28522333
[TBL] [Abstract][Full Text] [Related]
33. Challenges Associated With Applying Physiologically Based Pharmacokinetic Modeling for Public Health Decision-Making.
Tan YM; Worley RR; Leonard JA; Fisher JW
Toxicol Sci; 2018 Apr; 162(2):341-348. PubMed ID: 29385573
[TBL] [Abstract][Full Text] [Related]
34. A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures.
Haddad S; Béliveau M; Tardif R; Krishnan K
Toxicol Sci; 2001 Sep; 63(1):125-31. PubMed ID: 11509752
[TBL] [Abstract][Full Text] [Related]
35. Physiological-model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds.
Pelekis M; Gephart LA; Lerman SE
Regul Toxicol Pharmacol; 2001 Feb; 33(1):12-20. PubMed ID: 11259175
[TBL] [Abstract][Full Text] [Related]
36. Development of a human physiologically based pharmacokinetic (PBPK) model for phthalate (DEHP) and its metabolites: A bottom up modeling approach.
Sharma RP; Schuhmacher M; Kumar V
Toxicol Lett; 2018 Oct; 296():152-162. PubMed ID: 29958929
[TBL] [Abstract][Full Text] [Related]
37. Toxicokinetic modeling and its applications in chemical risk assessment.
Andersen ME
Toxicol Lett; 2003 Feb; 138(1-2):9-27. PubMed ID: 12559690
[TBL] [Abstract][Full Text] [Related]
38. Environmental risk assessment of selected organic chemicals based on TOC test and QSAR estimation models.
Chi Y; Zhang H; Huang Q; Lin Y; Ye G; Zhu H; Dong S
J Environ Sci (China); 2018 Feb; 64():23-31. PubMed ID: 29478644
[TBL] [Abstract][Full Text] [Related]
39. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
Kirman CR; Sweeney LM; Corley R; Gargas ML
Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
[TBL] [Abstract][Full Text] [Related]
40. A physiologically based kinetic modeling of ethyl tert-butyl ether in humans-An illustrative application of quantitative structure-property relationship and Monte Carlo simulation.
Watanabe-Matsumoto S; Yoshida K; Meiseki Y; Ishida S; Hirose A; Yamada T
J Toxicol Sci; 2022; 47(2):77-87. PubMed ID: 35110473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
